Technology area: Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
The National Institutes Of Health has 2 pending office actions within the Chemistry & Materials technology area. These actions are being handled by 2 distinct examiners and 2 distinct art units. This distribution shows that the organization's chemistry-related research is being reviewed by different specialized groups within the patent office.
Mohamed K Ahmed Ali is the busiest examiner for the portfolio, with 1 pending office action. The active matters are distributed such that each of the 2 distinct examiners is responsible for one matter. This prevents the organization's prosecution progress from being bottlenecked by a single examiner's workload or review style.
With the assigned art units involved, the organization must navigate different technical perspectives and divisional procedures. This diversification can be beneficial, as it allows for multiple parallel paths toward allowance. The successful resolution of the 2 pending actions will require a tailored approach for each examiner while maintaining the overall technical integrity of the chemistry and materials portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AHMED ALI, MOHAMED K | 1 | 70.9% | +26.6% |
| FRITCHMAN, REBECCA M | 1 | 45.6% | +35.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19002380 | TRANSFER OF NANOPARTICLES TO A SUBSTRATE | AHMED ALI, MOHAMED K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19002380 | TRANSFER OF NANOPARTICLES TO A SUBSTRATE | AHMED ALI, MOHAMED K | — |
| 18039641 | BIOMARKER AND TREATMENT FOR VASCULAR COGNITIVE IMPAIRMENT AND RELATED CONDITIONS | FRITCHMAN, REBECCA M | — |
| Art Unit | Apps |
|---|---|
| 1712 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19002380 | TRANSFER OF NANOPARTICLES TO A SUBSTRATE | AHMED ALI, MOHAMED K | 1712 | §103§112 | Non-Final OA | — | Pending | Dec 26, 2024 |
| 18039641 | BIOMARKER AND TREATMENT FOR VASCULAR COGNITIVE IMPAIRMENT AND RELATED CONDITIONS | FRITCHMAN, REBECCA M | 1758 | §103 | Non-Final OA | — | Pending | May 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational Institutes Of Health has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Mohamed K Ahmed Ali has the most, with 1 of National Institutes Of Health's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
